Literature DB >> 1171565

Acute treatment with calcitonin in primary hyperparathyroidism and severe hypercalcaemia of other origin.

H E Sjöberg, B Hjern.   

Abstract

Porcine or salmon calcitonin was given, as emergency treatment for 17 patients with hypercalcaemia, mostly of a severe degree. A lowering of serum calcium was achieved in all of 11 patients with primary hyperparathyroidism and in another 4 with malignancies. In most of the patients, the lowering of serum calcium level was accompanied by a pronounced clinical amelioration. This made possible successful parathyroidectomy without complications in the patients with primary hyperparathyroidism. In all patients except one, a decrease in serum creatinine was observed during treatment. Creatinine clearance was studied during calcitonin treatment in 2 patients and showed an increase. Calcitonin was ineffective in 2 of the patients with hypercalcaemia: one with plasmacell sarcoma of the lungs and another one with sarcoidosis. No serious side-effects were observed. Due to its quick action and lack of toxic effects, calcitonin is recommended when a prompt reduction of serum calcium is of vital importance.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1171565

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  5 in total

1.  25 years of salmon calcitonin: from synthesis to therapeutic use.

Authors:  M Azria; D H Copp; J M Zanelli
Journal:  Calcif Tissue Int       Date:  1995-12       Impact factor: 4.333

2.  Management of severe hypercalcaemia.

Authors: 
Journal:  Br Med J       Date:  1980-01-26

3.  Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

Authors:  R Civitelli; S Gonnelli; F Zacchei; S Bigazzi; A Vattimo; L V Avioli; C Gennari
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

4.  Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.

Authors:  D J Hosking; S R Heller
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Surgical resection of metastatic parathyroid carcinoma.

Authors:  M W Flye; M F Brennan
Journal:  Ann Surg       Date:  1981-04       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.